Pictet Asset Management
INDV icon

Pictet Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Pictet Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.55M Buy
261,381
+246,399
+1,645% +$8.14M 0.01% 707
2025
Q4 		$538K Sell
14,982
-190,481
-93% -$5.82M ﹤0.01% 1404
2025
Q3 		$4.95M Buy
205,463
+190,008
+1,229% +$3.98M ﹤0.01% 792
2025
Q2 		$230K Buy
15,455
+1,327
+9% +$15.5K ﹤0.01% 1767
2025
Q1 		$132K Hold
14,128
– – ﹤0.01% 1878
2024
Q4 		$181K Hold
14,128
– – ﹤0.01% 1875
2024
Q3 		$140K Hold
14,128
– – ﹤0.01% 1905
2024
Q2 		$221K Hold
14,128
– – ﹤0.01% 1708
2024
Q1 		$302K Buy
+14,128
New +$265K ﹤0.01% 1539

Other funds holding INDV

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return